Biotech

All Articles

ArsenalBio increases $325M, turns out of former lead possession

.Toolbox Biosciences is proceeding up. The tissue therapy provider has added $325 thousand in ammo a...

Lilly- backed fat loss biotech data IPO

.After increasing $170 million back in February, metabolic disease-focused BioAge Labs has filed to ...

Aelis' marijuana usage medication flunks stage 2b, steering Indivior to reconsider $100M option

.Aelis Farma's chances of getting a simple, good selection on a $one hundred thousand option repayme...

ProKidney halts period 3 trial certainly not needed to have for cell treatment confirmation

.ProKidney has actually quit one of a pair of phase 3 trials for its own cell therapy for kidney ail...

Vaxcyte rises on 'spectacular' 31-valent PCV succeed against Pfizer

.Vaxcyte introduced what experts referred to as "magnificent" stage 1/2 records for its own 31-valen...

Recursion's brain disease test presents little proof of efficiency

.Recursion has discovered via a very early test of its own tech-enabled method to medication explora...

Acepodia, Pfizer click on all together for chemistry-based cell treatment

.Phone it a case of excellent chemical make up: Acepodia, a biotech based upon Nobel Champion scienc...

Praxis epilepsy medicine lessens confiscations in period 2 trial

.Praxis Precision Medicines has scored an additional midphase succeed in epilepsy this year, with it...

Three execs resign as Dyne messages combined records for DMD prospect

.After getting away from a clinical grip several years back, Dyne Therapeutics has actually disclose...

Arrowhead fires off stage 3 information in unusual metabolic illness in front of market clash with Ionis

.Arrowhead Pharmaceuticals has revealed its give in front of a possible showdown along with Ionis, p...